Research News

Filter News By

Clear Filters

  1. CF Foundation Invests up to $14M in Effort to Solve Key Challenges to Gene Delivery in Cystic Fibrosis

    June 17, 2020

    The Cystic Fibrosis Foundation announced an investment in 4D Molecular Therapeutics to develop a customized vehicle to deliver a healthy CFTR gene into the lung cells of people with CF.

  2. CF Foundation Awards Up to $5.6 Million to Develop Novel Antibiotic to Fight Drug-Resistant Bacteria

    May 28, 2020

    The Cystic Fibrosis Foundation has awarded up to $5.6 million to Microbion Corporation to develop a novel, inhaled antibiotic to treat drug-resistant bacterial infections in people with cystic fibrosis.

  3. CF Foundation Awards Funding for First-Ever Controlled Clinical Study of Phage Therapy in CF

    March 18, 2020

    The Cystic Fibrosis Foundation awarded up to $5 million to Armata Pharmaceuticals for the first-ever controlled clinical study of phage therapy in CF, reaffirming the Foundation’s commitment to advance innovative solutions to the growing challenge of antibiotic resistance.

  4. CF Foundation Announces up to $5M Award to Support First-Ever Controlled Clinical Study of Phage Therapy in Cystic Fibrosis

    March 18, 2020

    Study reaffirms the Foundation’s commitment to advance solutions to the growing challenge of antibiotic resistance and evaluate the use of phage to treat infections for people with CF

  5. Cystic Fibrosis Foundation Supports Development of Non-Porcine Enzyme Therapy

    February 12, 2020

    The Cystic Fibrosis Foundation has entered into an agreement with Synspira Therapeutics Inc. to develop a non-porcine enzyme replacement therapy to offer an alternative to people with cystic fibrosis who cannot digest food properly.

  6. Cystic Fibrosis Foundation Launches $500 Million Path to a Cure

    October 30, 2019

    Nonprofit issues challenge to accelerate treatments for every person with CF
More Posts

Follow Us On